Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Trastuzumab Emtansine Improves Long-Term Survival in HER2 Breast Cancer Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with ...

In this case, a postmenopausal woman in her 50s with hypothyroidism underwent surgery for a left ovarian mass. Due to dense adhesions ... enabling successful interval debulking surgery. The patient ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Clea Shearer opens up to PEOPLE about the latest and unexpected surgery in her breast cancer journey, and how she’s using her ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

In his first interview since his wife's death, Caden Hutchins tells TODAY.com about her early symptoms and positive attitude ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

Last month, Texas plastic surgeon Elisabeth Potter posted on TikTok and Instagram that she had just been interrupted in the middle of a procedure for a breast cancer ... her to step out of surgery ...

Background: Variable rates of HER2 protein overexpression and gene ... (fluorescence in situ hybridization [FISH] positive) ovarian cancer progressing under taxane/carboplatin chemotherapy or ...